Mindable Panic & Agoraphobia
Commercial- Indications
- Panic disorder, Agoraphobia
Company intelligence / Profile preview
Mindable Health’s mobile applications for panic/agoraphobia and social phobia are CE-marked medical devices reimbursed by all statutory health insurance providers in Germany. Clinical studies show that after using the app for eight weeks, one in eight users was free of panic symptoms; after twelve weeks, users reported significantly less social anxiety[1]. The apps are developed with licensed psychotherapists.
User satisfaction rates are high—91% would recommend the app to others[1].
The products have been validated in real-world settings with positive outcomes for symptom reduction.
No pharmacological clinical trials; results pertain to digital intervention efficacy.
[References from user testimonials and company-reported studies.]
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mindable Health.